<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34053791</PMID><DateCompleted><Year>2021</Year><Month>07</Month><Day>08</Day></DateCompleted><DateRevised><Year>2023</Year><Month>07</Month><Day>17</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-2518</ISSN><JournalIssue CitedMedium="Internet"><Volume>39</Volume><Issue>28</Issue><PubDate><Year>2021</Year><Month>Jun</Month><Day>23</Day></PubDate></JournalIssue><Title>Vaccine</Title><ISOAbbreviation>Vaccine</ISOAbbreviation></Journal><ArticleTitle>Stopping a polio outbreak in the midst of war: Lessons from Syria.</ArticleTitle><Pagination><StartPage>3717</StartPage><EndPage>3723</EndPage><MedlinePgn>3717-3723</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.vaccine.2021.05.045</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0264-410X(21)00619-8</ELocationID><Abstract><AbstractText Label="BACKGROUND">Outbreaks of circulating vaccine-derived polioviruses (cVDPVs) pose a threat to the eventual eradication of all polioviruses. In 2017, an outbreak of cVDPV type 2 (cVDPV2) occurred in the midst of a war in Syria. We describe vaccination-based risk factors for and the successful response to the outbreak.</AbstractText><AbstractText Label="METHODS">We performed a descriptive analysis of cVDPV2 cases and key indicators of poliovirus surveillance and vaccination activities during 2016-2018. In the absence of reliable subnational coverage data, we used the caregiver-reported vaccination status of children with non-polio acute flaccid paralysis (AFP) as a proxy for vaccination coverage. We then estimated the relative odds of being unvaccinated against polio, comparing children in areas affected by the outbreak to children in other parts of Syria in order to establish the presence of poliovirus immunity gaps in outbreak affected areas.</AbstractText><AbstractText Label="FINDINGS">A total of 74 cVDPV2 cases were reported, with paralysis onset ranging from 3 March to 21 September 2017. All but three cases were reported from Deir-ez-Zor governorate and 84% had received&#x202f;&lt;&#x202f;3 doses of oral poliovirus vaccine (OPV). After adjusting for age and sex, non-polio AFP case-patients aged 6-59&#x202f;months in outbreak-affected areas had 2.5 (95% CI: 1.1-5.7) increased odds of being unvaccinated with OPV compared with non-polio AFP case-patients in the same age group in other parts of Syria. Three outbreak response rounds of monovalent OPV type 2 (mOPV2) vaccination were conducted, with governorate-level coverage mostly exceeding 80%.</AbstractText><AbstractText Label="INTERPRETATION">Significant declines in both national and subnational polio vaccination coverage, precipitated by war and a humanitarian crisis, led to a cVDPV2 outbreak in Syria that was successfully contained following three rounds of mOPV2 vaccination.</AbstractText><CopyrightInformation>Published by Elsevier Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mbaeyi</LastName><ForeName>Chukwuma</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>United States Centers for Disease Control and Prevention, 1600 Clifton Rd. NE, Atlanta, GA 30329, USA. Electronic address: cmbaeyi@cdc.gov.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moran</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>World Health Organization Headquarters, Avenue Appia 20, 1202 Geneva, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wadood</LastName><ForeName>Zubair</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>World Health Organization Headquarters, Avenue Appia 20, 1202 Geneva, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ather</LastName><ForeName>Fazal</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Middle East and North Africa Office, United Nations Children's Fund, Abdulqader Al-Abed Street, Building No. 15, Tla'a Al-Ali, Amman, Jordan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sykes</LastName><ForeName>Emma</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>World Health Organization, Regional Office for the Eastern Mediterranean, Mohammad Jamjoum Street, Ministry of Interior Circle Building No. 5, P.O. Box 811547, Amman 11181, Jordan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nikulin</LastName><ForeName>Joanna</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>World Health Organization, Regional Office for the Eastern Mediterranean, Mohammad Jamjoum Street, Ministry of Interior Circle Building No. 5, P.O. Box 811547, Amman 11181, Jordan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al Safadi</LastName><ForeName>Mohammad</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>World Health Organization Headquarters, Avenue Appia 20, 1202 Geneva, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stehling-Ariza</LastName><ForeName>Tasha</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>United States Centers for Disease Control and Prevention, 1600 Clifton Rd. NE, Atlanta, GA 30329, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zomahoun</LastName><ForeName>Laurel</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>World Health Organization Headquarters, Avenue Appia 20, 1202 Geneva, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ismaili</LastName><ForeName>Abdelkarim</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>World Health Organization, Regional Office for the Eastern Mediterranean, Mohammad Jamjoum Street, Ministry of Interior Circle Building No. 5, P.O. Box 811547, Amman 11181, Jordan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abourshaid</LastName><ForeName>Nidal</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Syria Country Office, United Nations Children's Fund, East Mazzeh, Al Shafiee St., Damascus, Syria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Asghar</LastName><ForeName>Humayun</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>World Health Organization, Regional Office for the Eastern Mediterranean, Mohammad Jamjoum Street, Ministry of Interior Circle Building No. 5, P.O. Box 811547, Amman 11181, Jordan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Korukluoglu</LastName><ForeName>Gulay</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Public Health Institutions of Turkey, Adnan Saygun Cad. No. 55, F Blok 06100 Sihhiye, Ankara, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Duizer</LastName><ForeName>Erwin</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>National Polio Laboratory, Centre for Infectious Disease Control, National Institute for Public Health and the Environment, P.O. Box 1, 3720 BA, Bilthoven, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ehrhardt</LastName><ForeName>Derek</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>United States Centers for Disease Control and Prevention, 1600 Clifton Rd. NE, Atlanta, GA 30329, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Burns</LastName><ForeName>Cara C</ForeName><Initials>CC</Initials><AffiliationInfo><Affiliation>United States Centers for Disease Control and Prevention, 1600 Clifton Rd. NE, Atlanta, GA 30329, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sharaf</LastName><ForeName>Magdi</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>World Health Organization, Regional Office for the Eastern Mediterranean, Mohammad Jamjoum Street, Ministry of Interior Circle Building No. 5, P.O. Box 811547, Amman 11181, Jordan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>001</GrantID><Acronym>WHO_</Acronym><Agency>World Health Organization</Agency><Country>International</Country></Grant><Grant><GrantID>CC999999</GrantID><Acronym>ImCDC</Acronym><Agency>Intramural CDC HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>05</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Vaccine</MedlineTA><NlmUniqueID>8406899</NlmUniqueID><ISSNLinking>0264-410X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011055">Poliovirus Vaccine, Oral</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004196" MajorTopicYN="N">Disease Outbreaks</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011051" MajorTopicYN="Y">Poliomyelitis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017955" MajorTopicYN="Y">Poliovirus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011055" MajorTopicYN="N">Poliovirus Vaccine, Oral</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013593" MajorTopicYN="N" Type="Geographic">Syria</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Conflict</Keyword><Keyword MajorTopicYN="N">Oral poliovirus vaccine</Keyword><Keyword MajorTopicYN="N">Outbreaks</Keyword><Keyword MajorTopicYN="N">Polio</Keyword><Keyword MajorTopicYN="N">Syria</Keyword><Keyword MajorTopicYN="N">Vaccine-derived polioviruses</Keyword></KeywordList><CoiStatement>Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>2</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>5</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>5</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>6</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>7</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>5</Month><Day>31</Day><Hour>5</Hour><Minute>51</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>7</Month><Day>14</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34053791</ArticleId><ArticleId IdType="mid">NIHMS1913111</ArticleId><ArticleId IdType="pmc">PMC10347301</ArticleId><ArticleId IdType="doi">10.1016/j.vaccine.2021.05.045</ArticleId><ArticleId IdType="pii">S0264-410X(21)00619-8</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Nathanson N, Kew OM. From emergence to eradication: the epidemiology of poliomyelitis deconstructed. Am J Epidemiol 2010;172:1213&#x2013;29.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2991634</ArticleId><ArticleId IdType="pubmed">20978089</ArticleId></ArticleIdList></Reference><Reference><Citation>Chard AN, Datta SD, Tallis G, et al. Progress Toward Polio Eradication &#x2014; Worldwide, January 2018&#x2013;March 2020. MMWR Morb Mortal Wkly Rep 2020;69:784&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7316320</ArticleId><ArticleId IdType="pubmed">32584798</ArticleId></ArticleIdList></Reference><Reference><Citation>Wassilak SG, Oberste MS, Tangermann RH, Diop OM, Jafari HS, Armstrong GL. Progress toward global interruption of wild poliovirus transmission, 2010&#x2013;2013, and tackling the challenges to complete eradication. J Infect Dis 2014;210:S5&#x2013;S15.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4615678</ArticleId><ArticleId IdType="pubmed">25316873</ArticleId></ArticleIdList></Reference><Reference><Citation>Moturi EK, Porter KA, Wassilak SGF, et al. Progress toward polio eradication&#x2014;worldwide, 2013&#x2013;2014. MMWR Morb Mortal Wkly Rep 2014;63:468&#x2013;72.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5779464</ArticleId><ArticleId IdType="pubmed">24871252</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson KM, Pallansch MA, Duintjer Tebbens RJ, Wassilak SGF, Kim JH, Cochi SL. Pre-eradication national vaccine policy options for poliovirus infection and disease3 control. Risk Anal 2013;33:516&#x2013;43.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7941951</ArticleId><ArticleId IdType="pubmed">23461599</ArticleId></ArticleIdList></Reference><Reference><Citation>Mbaeyi C, Ryan MJ, Smith P, et al. Response to a Large Polio Outbreak in a Setting of Conflict &#x2014; Middle East, 2013&#x2013;2015. MMWR Morb Mortal Wkly Rep 2017;66:227&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5657899</ArticleId><ArticleId IdType="pubmed">28253229</ArticleId></ArticleIdList></Reference><Reference><Citation>Roberts L A war within a war. Science 2014;343:1302&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">24653016</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharara SL, Kanj SS. War and infectious diseases: challenges of the Syrian civil war. PLoS Pathog. 2014;10(10):e1004438.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4231133</ArticleId><ArticleId IdType="pubmed">25393545</ArticleId></ArticleIdList></Reference><Reference><Citation>Ozaras R, Leblebicioglu H, Sunbul M, et al. The Syrian conflict and infectious diseases. Expert Rev Anti Infect Ther. 2016;14(6):547&#x2013;55.</Citation><ArticleIdList><ArticleId IdType="pubmed">27063349</ArticleId></ArticleIdList></Reference><Reference><Citation>Stone-Brown K Syria: a healthcare system on the brink of collapse. BMJ 2013;347:f7375.</Citation><ArticleIdList><ArticleId IdType="pubmed">24327182</ArticleId></ArticleIdList></Reference><Reference><Citation>Mbaeyi C, Wadood ZM, Moran T, et al. Strategic Response to an Outbreak of Circulating Vaccine-Derived Poliovirus Type 2 &#x2014; Syria, 2017&#x2013;2018. MMWR Morb Mortal Wkly Rep 2018;67:690&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6013082</ArticleId><ArticleId IdType="pubmed">29927908</ArticleId></ArticleIdList></Reference><Reference><Citation>Burns CC, Diop OM, Sutter RW, Kew OM. Vaccine-derived polioviruses. J Infect Dis. 2014;210(Suppl 1):S283&#x2013;93.</Citation><ArticleIdList><ArticleId IdType="pubmed">25316847</ArticleId></ArticleIdList></Reference><Reference><Citation>Kew O, Pallansch M. Breaking the Last Chains of Poliovirus Transmission: Progress and Challenges in Global Polio Eradication. Annu Rev Virol. 2018;5(1):427&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pubmed">30001183</ArticleId></ArticleIdList></Reference><Reference><Citation>Macklin G, Liao Y, Takane M, et al. Prolonged Excretion of Poliovirus among Individuals with Primary Immunodeficiency Disorder: An Analysis of the World Health Organization Registry. Front Immunol. 2017;8:1103.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5622164</ArticleId><ArticleId IdType="pubmed">28993765</ArticleId></ArticleIdList></Reference><Reference><Citation>Jorba J, Diop OM, Iber J, et al. Update on Vaccine-Derived Polioviruses &#x2014; Worldwide, January 2017&#x2013;June 2018. MMWR Morb Mortal Wkly Rep 2018;67:1189&#x2013;94.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6290814</ArticleId><ArticleId IdType="pubmed">30359342</ArticleId></ArticleIdList></Reference><Reference><Citation>Jorba J, Diop OM, Iber J, et al. Update on Vaccine-Derived Poliovirus Outbreaks &#x2014; Worldwide, January 2018&#x2013;June 2019. MMWR Morb Mortal Wkly Rep 2019;68:1024&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6855511</ArticleId><ArticleId IdType="pubmed">31725706</ArticleId></ArticleIdList></Reference><Reference><Citation>Hampton LM, Farrell M, Ramirez-Gonzalez A, et al. Cessation of Trivalent Oral Poliovirus Vaccine and Introduction of Inactivated Poliovirus Vaccine &#x2014; Worldwide, 2016. MMWR Morb Mortal Wkly Rep 2016;65:934&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">27606675</ArticleId></ArticleIdList></Reference><Reference><Citation>Koopman JS. Models and analyses to understand threats to polio eradication. BMC Med. 2017. 22;15(1):221.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5740775</ArticleId><ArticleId IdType="pubmed">29268738</ArticleId></ArticleIdList></Reference><Reference><Citation>Moffett DB, Llewellyn A, Singh H, et al. Progress Toward Poliovirus Containment Implementation &#x2014; Worldwide, 2018&#x2013;2019. MMWR Morb Mortal Wkly Rep 2019;68:825&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6762185</ArticleId><ArticleId IdType="pubmed">31557146</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson KM, Duintjer Tebbens RJ. Modeling the dynamics of oral poliovirus vaccine cessation. J Infect Dis 2014;210:475&#x2013;84.</Citation><ArticleIdList><ArticleId IdType="pubmed">25316870</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson KM, Pallansch MA, Duintjer Tebbens RJ, Wassilak SGF, Cochi SL. Modeling population immunity to support efforts to end the transmission of live polioviruses. Risk Anal 2013;33:647&#x2013;63.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7896539</ArticleId><ArticleId IdType="pubmed">22985171</ArticleId></ArticleIdList></Reference><Reference><Citation>Duintjer Tebbens RJ, Thompson KM. Modeling the potential role of inactivated poliovirus vaccine to manage the risks of oral poliovirus vaccine cessation. J Infect Dis 2014;210:485&#x2013;97.</Citation><ArticleIdList><ArticleId IdType="pubmed">25316871</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization. Vaccine-preventable diseases: monitoring system 2019 global summary. Geneva, Switzerland: World Health Organization; 2019. http://apps.who.int/immunization_monitoring/globalsummary. Accessed 14 February 2020.</Citation></Reference><Reference><Citation>World Health Organization. Circulating vaccine-derived poliovirus type 2 &#x2013; Syrian Arab Republic. Disease Outbreak News, 13
June
2017. https://www.who.int/csr/don/13-June-2017-polio-syrian-arab-republic/en/. Accessed 5 May 2021.</Citation></Reference><Reference><Citation>Global Polio Eradication Initiative. Standard operating procedures: responding to a poliovirus event or outbreak, November 2017. Geneva, Switzerland: World Health Organization, Global Polio Eradication Initiative; 2017. http://polioeradication.org/wp-content/uploads/2018/01/pol-sop-responding-polioevent-outbreak-part1-20180117.pdf.</Citation></Reference><Reference><Citation>Patel JC, Diop OM, Gardner T, et al. Surveillance to Track Progress Toward Polio Eradication &#x2014; Worldwide, 2017&#x2013;2018. MMWR Morb Mortal Wkly Rep 2019;68:312&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6611474</ArticleId><ArticleId IdType="pubmed">30946737</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization. Outbreak surveillance and response in humanitarian emergencies: WHO guidelines for EWARN implementation
Geneva, Switzerland: World Health Organization; 2012. https://www.who.int/diseasecontrol_emergencies/publications/who_hse_epr_dce_2012.1/en/. Accessed 14 February 2020.</Citation></Reference><Reference><Citation>Duintjer Tebbens RJ, Pallansch MA, Kew OM, et al. Risks of paralytic disease due to wild or vaccine-derived poliovirus after eradication. Risk Anal 2006;26:1471&#x2013;505.</Citation><ArticleIdList><ArticleId IdType="pubmed">17184393</ArticleId></ArticleIdList></Reference><Reference><Citation>Duintjer Tebbens RJ, Pallansch MA, Kim JH, et al. Oral poliovirus vaccine evolution and insights relevant to modeling the risks of circulating vaccine-derived polioviruses. Risk Anal 2013;33:680&#x2013;702.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7890645</ArticleId><ArticleId IdType="pubmed">23470192</ArticleId></ArticleIdList></Reference><Reference><Citation>Aburas R, Najeeb A, Baageel L, et al. The Syrian conflict: a case study of the challenges and acute need for medical humanitarian operations for women and children internally displaced persons. BMC Med. 2018;16:65.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5946430</ArticleId><ArticleId IdType="pubmed">29747641</ArticleId></ArticleIdList></Reference><Reference><Citation>Doganay M, Demiraslan H. Refugees of the Syrian Civil War: Impact on Reemerging Infections, Health Services, and Biosecurity in Turkey. Health Secur. 2016;14(4):220&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">27362427</ArticleId></ArticleIdList></Reference><Reference><Citation>Kennedy J, Michailidou D. Civil war, contested sovereignty and the limits of global health partnerships: A case study of the Syrian polio outbreak in 2013. Health Policy Plan. 2017;32(5):690&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">28453719</ArticleId></ArticleIdList></Reference><Reference><Citation>Mbaeyi C, Alleman MM, Ehrhardt D, et al. Update on Vaccine-Derived Poliovirus Outbreaks &#x2014; Democratic Republic of the Congo and Horn of Africa, 2017&#x2013;2018. MMWR Morb Mortal Wkly Rep 2019;68:225&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6421971</ArticleId><ArticleId IdType="pubmed">30845121</ArticleId></ArticleIdList></Reference><Reference><Citation>Bauri M, Wilkinson AL, Ropa B, et al. Notes from the Field: Circulating Vaccine-Derived Poliovirus Type 1 and Outbreak Response &#x2014; Papua New Guinea, 2018. MMWR Morb Mortal Wkly Rep 2019;68:119&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6366675</ArticleId><ArticleId IdType="pubmed">30730867</ArticleId></ArticleIdList></Reference><Reference><Citation>Eboh VA, Makam JK, Chitale RA, et al. Notes from the Field: Widespread Transmission of Circulating Vaccine-Derived Poliovirus Identified by Environmental Surveillance and Immunization Response &#x2014; Horn of Africa, 2017&#x2013;2018. MMWR Morb Mortal Wkly Rep 2018;67:787&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6053998</ArticleId><ArticleId IdType="pubmed">30024868</ArticleId></ArticleIdList></Reference><Reference><Citation>Nnadi C, Damisa E, Esapa L, et al. Continued Endemic Wild Poliovirus Transmission in Security-Compromised Areas &#x2014; Nigeria, 2016. MMWR Morb Mortal Wkly Rep 2017;66:190&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5657850</ArticleId><ArticleId IdType="pubmed">28233765</ArticleId></ArticleIdList></Reference><Reference><Citation>Vallejo C, Pearson CAB, Koopman J, Hladish TJ. Evaluating the probability of silent circulation of polio in small populations using the silent circulation statistic. Infect Dis Model. 2019;4:239&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6606837</ArticleId><ArticleId IdType="pubmed">31312777</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson KM, Duintjer Tebbens RJ, Pallansch MA. Evaluation of response scenarios to potential polio outbreaks using mathematical models. Risk Anal 2006;26:1541&#x2013;56.</Citation><ArticleIdList><ArticleId IdType="pubmed">17184396</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>